Publications by authors named "Ekaterina Bourova-Flin"

Malignant forms of breast cancer refractory to existing therapies remain a major unmet health issue, primarily due to metastatic spread. A better understanding of the mechanisms at play will provide better insights for alternative treatments to prevent breast cancer cell dispersion. Here, we identify the lysine methyltransferase SMYD2 as a clinically actionable master regulator of breast cancer metastasis.

View Article and Find Full Text PDF
Article Synopsis
  • Malignant breast cancer is a significant health challenge due to its tendency to metastasize, making current therapies ineffective for some patients.
  • Researchers have identified the lysine methyltransferase SMYD2 as a key factor in breast cancer metastasis, which is overexpressed in aggressive forms of the disease but isn't essential for primary tumor growth.
  • Targeting the SMYD2-BCAR3-FMNL signaling pathway could provide new treatment options to prevent the spread of breast cancer, as inhibiting SMYD2 has been shown to reduce metastasis in various mouse models.
View Article and Find Full Text PDF

The synthesis of fatty acids from acetyl-coenzyme A (AcCoA) is deregulated in diverse pathologies, including cancer. Here, we report that fatty acid accumulation is negatively regulated by nucleoside diphosphate kinases 1 and 2 (NME1/2), housekeeping enzymes involved in nucleotide homeostasis that were recently found to bind CoA. We show that NME1 additionally binds AcCoA and that ligand recognition involves a unique binding mode dependent on the CoA/AcCoA 3' phosphate.

View Article and Find Full Text PDF

Background: In breast cancer, as in all cancers, genetic and epigenetic deregulations can result in out-of-context expressions of a set of normally silent tissue-specific genes. The activation of some of these genes in various cancers empowers tumours cells with new properties and drives enhanced proliferation and metastatic activity, leading to a poor survival prognosis.

Results: In this work, we undertook an unprecedented systematic and unbiased analysis of out-of-context activations of a specific set of tissue-specific genes from testis, placenta and embryonic stem cells, not expressed in normal breast tissue as a source of novel prognostic biomarkers.

View Article and Find Full Text PDF

Background: Acetylation and trimethylation of histone H3 lysine 27 (H3K27ac and H3K27me3) generally activate and repress transcription, respectively. Concurrent activation of H3K27ac and H3K27me3 has been reported to correlate with poor prognosis in hepatocellular carcinoma. A high level of H3K27me3 has been shown to be associated with advanced oral squamous cell carcinoma (OSCC) tumour stage, but prognostic impact of H3K27ac level alone/or in combination with H3K27me3 in OSCC patients had not yet been reported.

View Article and Find Full Text PDF

Background: Altered acetyl CoA acetyltransferase 1 (ACAT1) expression has been reported in diverse cancers. However, the expression of ACAT1 and its prognostic value in oral squamous cell carcinoma (OSCC) has remained unexplored.

Materials And Methods: In this study, the expression of ACAT1 was analysed by immunohistochemistry (IHC) in 61 OSCC patients and compared between OSCC and adjacent pre-tumour tissue of 21 patients.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on developing a new therapeutic vaccine using allogeneic plasmacytoid dendritic cells to boost the immune response against lung cancer, particularly non-small-cell lung cancer (NSCLC).
  • Despite the promise of immune checkpoint inhibitors (ICIs), many patients don't respond, which the researchers aim to improve with this vaccine.
  • The results show that 69% of patients experienced efficient activation of CD8+ T cells against tumor antigens, especially when combined with anti-PD-1 antibodies, highlighting the vaccine's potential effectiveness in conjunction with existing therapies.
View Article and Find Full Text PDF

Background: T cell acute lymphoblastic leukemia (T-ALL) defines a group of hematological malignancies with heterogeneous aggressiveness and highly variable outcome, making therapeutic decisions a challenging task. We tried to discover new predictive model for T-ALL before treatment by using a specific pipeline designed to discover aberrantly active gene.

Results: The expression of 18 genes was significantly associated with shorter survival, including ACTRT2, GOT1L1, SPATA45, TOPAZ1 and ZPBP (5-GEC), which were used as a basis to design a prognostic classifier for T-ALL patients.

View Article and Find Full Text PDF

Background: Exposure to phthalates during pregnancy may alter DNA methylation in the placenta, a crucial organ for the growth and development of the fetus.

Objectives: We studied associations between urinary concentrations of phthalate biomarkers during pregnancy and placental DNA methylation.

Methods: We measured concentrations of 11 phthalate metabolites in maternal spot urine samples collected between 22 and 29 gestational weeks in 202 pregnant women.

View Article and Find Full Text PDF

T-cell acute lymphoblastic leukemia (T-ALL) is one of the most dangerous hematological malignancies, with high tumor heterogeneity and poor prognosis. More than 60% of T-ALL patients carry NOTCH1 gene mutations, leading to abnormal expression of downstream target genes and aberrant activation of various signaling pathways. We found that chidamide, an HDAC inhibitor, exerts an antitumor effect on T-ALL cell lines and primary cells including an anti-NOTCH1 activity.

View Article and Find Full Text PDF
Article Synopsis
  • In utero exposure to synthetic phenols like triclosan can affect DNA methylation in the placenta, a crucial organ for fetal growth.
  • A study of 202 mother-son pairs analyzed urine samples for phenol levels during pregnancy and examined placental DNA for methylation changes.
  • The research found 46 differentially methylated regions linked to phenol exposure, especially triclosan, which may influence gene activity related to cell functions and cancer risk, with placental cell diversity playing a role in these effects.
View Article and Find Full Text PDF

In addition to acetylation, histones are modified by a series of competing longer-chain acylations. Most of these acylation marks are enriched and co-exist with acetylation on active gene regulatory elements. Their seemingly redundant functions hinder our understanding of histone acylations' specific roles.

View Article and Find Full Text PDF

Background: Large-scale genetic and epigenetic deregulations enable cancer cells to ectopically activate tissue-specific expression programmes. A specifically designed strategy was applied to oral squamous cell carcinomas (OSCC) in order to detect ectopic gene activations and develop a prognostic stratification test.

Methods: A dedicated original prognosis biomarker discovery approach was implemented using genome-wide transcriptomic data of OSCC, including training and validation cohorts.

View Article and Find Full Text PDF

Background: Although exposure to cigarette smoking during pregnancy has been associated with alterations of DNA methylation in the cord blood or placental cells, whether such exposure before pregnancy could induce epigenetic alterations in the placenta of former smokers has never been investigated.

Methods: Our approach combined the analysis of placenta epigenomic (ENCODE) data with newly generated DNA methylation data obtained from 568 pregnant women, the largest cohort to date, either actively smoking during their pregnancy or formerly exposed to tobacco smoking.

Results: This strategy resulted in several major findings.

View Article and Find Full Text PDF

The discoid shape of resting platelets is maintained by a peripheral, circular bundle of microtubules called marginal band. Marginal band microtubules are acetylated on lysine 40 of the alpha-tubulin subunits. We have previously shown that the deacetylase HDAC6 is responsible for tubulin deacetylation in platelets and that the hyperacetylated state of the microtubules in platelets correlates with faster activation/spreading kinetics, pointing to a regulatory role of this modification.

View Article and Find Full Text PDF

Malignant cell transformation could be considered as a series of cell reprogramming events driven by oncogenic transcription factors and upstream signalling pathways. Chromatin plasticity and dynamics are critical determinants in the control of cell reprograming. An increase in chromatin dynamics could therefore constitute an essential step in driving oncogenesis and in generating tumour cell heterogeneity, which is indispensable for the selection of aggressive properties, including the ability of cells to disseminate and acquire resistance to treatments.

View Article and Find Full Text PDF
Article Synopsis
  • Nut is an oncogenic protein associated with NUT midline carcinoma, but its role in male germ cell development has been poorly understood.
  • The study finds that Nut is expressed in post-meiotic spermatogenic cells and is vital for histone H4 hyperacetylation, which is crucial for the transition from histones to protamines during sperm development.
  • Inactivating Nut leads to male sterility by halting spermatogenesis at the histone removal stage, revealing its critical role in genome compaction in male germ cells.
View Article and Find Full Text PDF

Background: Air pollution exposure represents a major health threat to the developing foetus. DNA methylation is one of the most well-known molecular determinants of the epigenetic status of cells. Blood DNA methylation has been proven sensitive to air pollutants, but the molecular impact of air pollution on new-borns has so far received little attention.

View Article and Find Full Text PDF

Cancer cells have recently been shown to activate hundreds of normally silent tissue-restricted genes, including a specific subset associated with cancer progression and poor prognosis. Within these genes, a class of testis-specific genes designed as cancer/testis, attracted special attention because of their oncogenic roles as well as their potential use in immunotherapy. Here we focus on one of these genes encoding the testis-specific member of the bromodomain and extra-terminal (BET) family, known as BRDT.

View Article and Find Full Text PDF